| Literature DB >> 28094495 |
Ravit Malishev1,2, Shira Shaham-Niv1,2, Sukhendu Nandi1,2, Sofiya Kolusheva1,2, Ehud Gazit1,2, Raz Jelinek1,2.
Abstract
Bacoside-A, a family of compounds extracted from the Bacopa monniera plant, is a folk-medicinal substance believed to exhibit therapeutic properties, particularly enhancing cognitive functions and improving memory. We show that bacoside-A exerted significant inhibitory effects upon cytotoxicity, fibrillation, and particularly membrane interactions of amyloid-beta (1-42) (Aβ42), the peptide playing a prominent role in Alzeheimer's disease progression and toxicity. Specifically, preincubation of bacoside-A with Aβ42 significantly reduced cell toxicity and inhibited fibril formation both in buffer solution and, more significantly, in the presence of membrane vesicles. In parallel, spectroscopic and microscopic analyses reveal that bacoside-A blocked membrane interactions of Aβ42, while formation of Aβ42 oligomers was not disrupted. These interesting phenomena suggest that inhibition of Aβ42 oligomer assembly into mature fibrils, and blocking membrane interactions of the oligomers are likely the underlying factors for ameliorating amyloid toxicity by bacoside-A and its putative physiological benefits.Entities:
Keywords: amyloid−membrane interactions; bacoside-A; fibrillation inhibitors; fluorescence anisotropy; giant vesicles; β-Amyloid; β-amyloid oligomers
Mesh:
Substances:
Year: 2017 PMID: 28094495 DOI: 10.1021/acschemneuro.6b00438
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418